This company listing is no longer active
Mithra Pharmaceuticals Crecimiento futuro
Future controles de criterios 5/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Mithra Pharmaceuticals de 100.7% y 43.1%, respectivamente.
Información clave
100.7%
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Pharmaceuticals | 15.8% |
| Tasa de crecimiento de los ingresos | 43.1% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 06 May 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%
Apr 06
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive
Feb 07Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts
Nov 09These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts
Oct 05Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)
May 23Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts
Aug 11Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%
Mar 13Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt
Dec 22Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 24Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt
Jun 07When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?
May 10Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?
Mar 18We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings
Feb 16Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long
Jan 21
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 29Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 137 | 44 | N/A | N/A | 1 |
| 12/31/2025 | 96 | 14 | N/A | N/A | 1 |
| 12/31/2024 | 44 | -55 | N/A | N/A | 1 |
| 12/31/2023 | 40 | -174 | -2 | -2 | N/A |
| 9/30/2023 | 51 | -126 | -15 | -6 | N/A |
| 6/30/2023 | 63 | -79 | -28 | -9 | N/A |
| 3/31/2023 | 65 | -69 | -55 | -33 | N/A |
| 12/31/2022 | 67 | -60 | -82 | -57 | N/A |
| 9/30/2022 | 44 | -76 | -92 | -68 | N/A |
| 6/30/2022 | 22 | -93 | -102 | -78 | N/A |
| 3/31/2022 | 22 | -105 | -100 | -78 | N/A |
| 12/31/2021 | 23 | -117 | -98 | -77 | N/A |
| 9/30/2021 | 21 | -115 | -94 | -75 | N/A |
| 6/30/2021 | 19 | -113 | -91 | -73 | N/A |
| 3/31/2021 | 14 | -103 | -94 | -77 | N/A |
| 12/31/2020 | 9 | -92 | -96 | -80 | N/A |
| 9/30/2020 | 44 | -31 | -85 | -70 | N/A |
| 6/30/2020 | 79 | 29 | -73 | -59 | N/A |
| 3/31/2020 | 88 | 1 | -68 | -53 | N/A |
| 12/31/2019 | 97 | -27 | -62 | -47 | N/A |
| 9/30/2019 | 84 | -54 | -42 | -28 | N/A |
| 6/30/2019 | 71 | -82 | -21 | -5 | N/A |
| 3/31/2019 | 64 | -55 | -14 | -1 | N/A |
| 12/31/2018 | 58 | -28 | -7 | 4 | N/A |
| 9/30/2018 | 46 | -41 | -23 | -9 | N/A |
| 6/30/2018 | 33 | -53 | -40 | -25 | N/A |
| 3/31/2018 | 33 | -46 | -44 | -28 | N/A |
| 12/31/2017 | 32 | -38 | -47 | -31 | N/A |
| 9/30/2017 | 26 | -37 | N/A | -32 | N/A |
| 6/30/2017 | 20 | -36 | N/A | -32 | N/A |
| 3/31/2017 | 21 | -36 | N/A | -28 | N/A |
| 12/31/2016 | 22 | -35 | N/A | -23 | N/A |
| 9/30/2016 | 21 | -29 | N/A | -23 | N/A |
| 6/30/2016 | 20 | -23 | N/A | -22 | N/A |
| 3/31/2016 | 20 | -16 | N/A | -20 | N/A |
| 12/31/2015 | 20 | -10 | N/A | -18 | N/A |
| 9/30/2015 | 19 | -9 | N/A | -15 | N/A |
| 6/30/2015 | 18 | -8 | N/A | -12 | N/A |
| 3/31/2015 | 19 | -5 | N/A | -6 | N/A |
| 12/31/2014 | 19 | -3 | N/A | -1 | N/A |
| 12/31/2013 | 18 | -2 | N/A | 1 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que MITRA sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (1.3%).
Beneficios vs. Mercado: Se prevé que MITRA sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.
Beneficios de alto crecimiento: Se espera que MITRA sea rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (43.1% al año) de MITRA crezcan más rápidamente que los del mercado Belgian (7.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos (43.1% al año) de MITRA crezcan más rápidamente que un 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de MITRA se prevé que sea elevada dentro de 3 años.